Skip to content

Pain Sensitivity Questionnaire and Postoperative Opioid Requirement

A Cohort Study on Association Between Pain Sensitivity by Pain Sensitivity Questionnaire and Postoperative Opioid Requirement

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04143672
Enrollment
110
Registered
2019-10-29
Start date
2019-11-30
Completion date
2020-10-31
Last updated
2019-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

postoperative pain, pain sensitivity

Brief summary

This study aims to investigate the potential association between pain sensitivity questionnaire score, the severity of postoperative pain, and postoperative analgesic requirement in patients with open colorectal cancer surgery. This information may be used to guide the optimal postoperative pain management, and ultimately improve patient's quality of life.

Detailed description

We plan to investigate the predictive ability of the PSQ as well as experimental parameters of pain sensitivity using electronic algometer and other known risk factors for postoperative pain in 100 patients scheduled for open colorectal cancer surgery. The following items are investigated before surgery; Age, sex, level of education, type of surgery, past surgical history, presence of chronic pain, the expected maximal pain score (VAS) after surgery, Pain catastrophizing scale, anxiety scale (HADS-A), Pain sensitivity questionnaire, and pain threshold measured by electronic algometer. The total opioid consumption is investigated for 24 and 48 hours after surgery. In addition, the severity of postoperative pain is measured by the 11-point VAS at 24 and 48 hours after surgery. Patient satisfaction with postoperative pain control is also investigated at 48 hours after surgery using the 7-point patient's satisfaction scale.

Interventions

DEVICEElectronic digital pressure algometer

Evaluation of pain threshold using an algometer is conducted one day before surgery. The pressure of the plunger of algometer is applied vertically to the patient's right thenar muscle belly at a speed of 10 N/sec by the tester. Then the tester removes the algometer when the patients start to feel pain and record the pressure recorded on the algometer.

DIAGNOSTIC_TESTPain sensitivity questionnaire

Evaluation of pain threshold using the Korean-version pain sensitivity questionnaire is conducted one day before surgery.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Intervention model description

Prospective observational study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or above * Patients scheduled for open colorectal cancer surgery under general anesthesia * ASA status I-III * Ability to read and understand the information sheet, questionnaires, and the - consent form * Patients scheduled for using IV-PCA after surgery

Exclusion criteria

* Unable to read and understand the information sheet, questionnaires, and the consent form * Severe medical or psychological diseases * Patients with preoperative chronic pain

Design outcomes

Primary

MeasureTime frameDescription
Total fentanyl consumption during 24 hourspostoperative 24 hourspostoperative fentanyl consumption (mcg) via IV patient controlled analgesia
Total fentanyl consumption during 48 hourspostoperative 48 hourspostoperative fentanyl consumption (mcg) via IV patient controlled analgesia

Secondary

MeasureTime frameDescription
Postoperative pain scorepostoperative 24, 48 hours11-pointed NRS pain score at resting/coughing/movement NRS (0-10): 0, no pain; 10, worst pain imaginable
Patient satisfaction for postoperative pain managementpostoperative 48 hours7-pointed likert scale (very satisfied-somewhat satisfied-satisfied-neutral-dissatisfied-somewhat dissatisfied-very dissatisfied)

Contacts

Primary ContactJintae Kim, MD, PhD
jintae73@gmail.com82-2-2072-3295
Backup ContactHojin Lee, MD
zenerdiode03@gmail.com82-2-2072-2467

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026